Ritu Baral

Stock Analyst at TD Cowen

(2.96)
# 1,271
Out of 5,154 analysts
45
Total ratings
40%
Success rate
2.88%
Average return

Stocks Rated by Ritu Baral

ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Buy
Price Target: $35$37
Current: $22.16
Upside: +66.97%
Krystal Biotech
Jan 9, 2026
Maintains: Buy
Price Target: $202$306
Current: $253.69
Upside: +20.62%
vTv Therapeutics
Jan 5, 2026
Initiates: Buy
Price Target: $67
Current: $35.22
Upside: +90.23%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $269$241
Current: $140.13
Upside: +71.98%
Palvella Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $97$133
Current: $134.39
Upside: -1.03%
Milestone Pharmaceuticals
Dec 15, 2025
Upgrades: Buy
Price Target: $8
Current: $1.58
Upside: +406.33%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $251$353
Current: $310.71
Upside: +13.61%
Vera Therapeutics
Dec 5, 2025
Maintains: Buy
Price Target: $60$73
Current: $39.07
Upside: +86.84%
Madrigal Pharmaceuticals
Aug 26, 2025
Maintains: Buy
Price Target: $390$554
Current: $432.83
Upside: +27.99%
Spero Therapeutics
Nov 18, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.30
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $2.85
Upside: -
Maintains: Buy
Price Target: $282$371
Current: $320.66
Upside: +15.70%
Initiates: Outperform
Price Target: n/a
Current: $5.41
Upside: -
Maintains: Outperform
Price Target: $125$175
Current: $16.71
Upside: +947.28%
Downgrades: Market Perform
Price Target: n/a
Current: $55.87
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $10.91
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $15.93
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $3.39
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $42.82
Upside: -
Initiates: Outperform
Price Target: n/a
Current: $1.33
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $0.32
Upside: -
Downgrades: Market Perform
Price Target: n/a
Current: $574.01
Upside: -